-
摘要: 铁死亡是近年来发现的一种铁依赖的非凋亡程序性细胞死亡，由过度的脂质过氧化引起。作为一种新的细胞死亡方式，铁死亡在癌症治疗方面的应用引起了众多学者的关注，有望成为肿瘤精准治疗的潜在靶点。肾癌是泌尿系统最常见的肿瘤之一，其对于铁死亡有较高的敏感性，目前已有大量研究表明靶向诱导铁死亡可以有效地杀死肾癌细胞并阻止肿瘤的生长，因此，对其进一步研究将有助于我们了解铁死亡与肾癌之间的联系，为肾癌的治疗寻找新的途径。Abstract: Ferroptosis is an iron dependent non-apoptotic programmed cell death found in recent years, which is caused by excessive lipid peroxidation. As a new way of cell death, the application of ferroptosis in cancer treatment has attracted the attention of many scholars, and is expected to become a potential target for precise tumor treatment. Renal cell carcinoma is one of the most common tumors in the urinary system. It has high sensitivity to ferroptosis. At present, a large number of studies have shown that targeted induction of ferroptosis can effectively kill renal cancer cells and prevent tumor growth. Therefore, further research on renal cell carcinoma will help us understand the relationship between ferroptosis and renal cancer and find a new way for the treatment of renal cancer.
-
Key words:
- ferroptosis /
- renal cell carcinoma /
- tumor microenvironment
-
-
[1] Fricker M, Tolkovsky AM, Borutaite V, et al. Neuronal Cell Death[J]. Physiol Rev, 2018, 98(2): 813-880. doi: 10.1152/physrev.00011.2017
[2] Zhang Y, Shi J, Liu X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression[J]. Nat Cell Biol, 2018, 20(10): 1181-1192. doi: 10.1038/s41556-018-0178-0
[3] Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression[J]. Trends Cell Biol, 2012, 22(2): 97-106. doi: 10.1016/j.tcb.2011.10.006
[4] Dolma S, Lessnick SL, Hahn WC, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell, 2003, 3(3): 285-296. doi: 10.1016/S1535-6108(03)00050-3
[5] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072. doi: 10.1016/j.cell.2012.03.042
[6] Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]. Chem Biol, 2008, 15(3): 234-245. doi: 10.1016/j.chembiol.2008.02.010
[7] D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy[J]. Cell Biol Int, 2019, 43(6): 582-592. doi: 10.1002/cbin.11137
[8] Gaschler MM, Stockwell BR. Lipid peroxidation in cell death[J]. Biochem Biophys Res Commun, 2017, 482(3): 419-425. doi: 10.1016/j.bbrc.2016.10.086
[9] Brigelius-Flohé R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis[J]. Biochim Biophys Acta, 2009, 1790(11): 1555-1568. doi: 10.1016/j.bbagen.2009.03.006
[10] Chen L, Hambright WS, Na R, et al. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis[J]. J Biol Chem, 2015, 290(47): 28097-28106. doi: 10.1074/jbc.M115.680090
[11] Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins[J]. J Biol Chem, 1999, 274(17): 11455-11458. doi: 10.1074/jbc.274.17.11455
[12] Yu H, Guo P, Xie X, et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases[J]. J Cell Mol Med, 2017, 21(4)657.
[13] Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015, 520(7545): 57-62. doi: 10.1038/nature14344
[14] Liu DS, Duong CP, Haupt S, et al. Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulation[J]. Nat Commun, 2017, 8: 14844. doi: 10.1038/ncomms14844
[15] Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease[J]. Trends Biochem Sci, 2016, 41(3): 274-286. doi: 10.1016/j.tibs.2015.11.012
[16] Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ, 2019, 26(11): 2329-2343. doi: 10.1038/s41418-019-0304-y
[17] Mao C, Wang X, Liu Y, et al. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53[J]. Cancer Res, 2018, 78(13): 3484-3496. doi: 10.1158/0008-5472.CAN-17-3454
[18] Inamura K. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification[J]. Int J Mol Sci, 2017, 18(10): 2195. doi: 10.3390/ijms18102195
[19] Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours[J]. Eur Urol, 2016, 70(1): 106-119. doi: 10.1016/j.eururo.2016.02.028
[20] Choueiri TK, Motzer RJ. Systemic Therapy for Metastatic Renal-Cell Carcinoma[J]. N Engl J Med, 2017, 376(4): 354-366. doi: 10.1056/NEJMra1601333
[21] Das M. Combined treatment for locally advanced pancreatic cancer[J]. Lancet Oncol, 2019, 20(7): e351. doi: 10.1016/S1470-2045(19)30381-X
[22] Gai C, Yu M, Li Z, et al. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer[J]. J Cell Physiol, 2020, 235(4): 3329-3339. doi: 10.1002/jcp.29221
[23] Miess H, Dankworth B, Gouw AM, et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma[J]. Oncogene, 2018, 37(40): 5435-5450. doi: 10.1038/s41388-018-0315-z
[24] Nie J, Lin B, Zhou M, et al. Role of ferroptosis in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2018, 144(12): 2329-2337. doi: 10.1007/s00432-018-2740-3
[25] Zhang Y, Zhuang L, Gan B. BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression[J]. Mol Cell Oncol, 2019, 6(1): 1536845. doi: 10.1080/23723556.2018.1536845
[26] Gan B. DUBbing Ferroptosis in Cancer Cells[J]. Cancer Res, 2019, 79(8): 1749-1750. doi: 10.1158/0008-5472.CAN-19-0487
[27] Cramer SL, Saha A, Liu J, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth[J]. Nat Med, 2017, 23(1): 120-127. doi: 10.1038/nm.4232
[28] Kerins MJ, Milligan J, Wohlschlegel JA, et al. Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction[J]. Cancer Sci, 2018, 109(9): 2757-2766. doi: 10.1111/cas.13701
[29] Shin D, Kim EH, Lee J, et al. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer[J]. Free Radic Biol Med, 2018, 129: 454-462. doi: 10.1016/j.freeradbiomed.2018.10.426
[30] Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition[J]. Nature, 2017, 551(7679): 247-250. doi: 10.1038/nature24297
[31] Markowitsch SD, Schupp P, Lauckner J, et al. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis[J]. Cancers(Basel), 2020, 12(11): 3150.
[32] Schonberg DL, Miller TE, Wu Q, et al. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells[J]. Cancer Cell, 2015, 28(4): 441-455. doi: 10.1016/j.ccell.2015.09.002
[33] Mai TT, Hamaï A, Hienzsch A, et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes[J]. Nat Chem, 2017, 9(10): 1025-1033. doi: 10.1038/nchem.2778
[34] Shen Z, Song J, Yung BC, et al. Emerging Strategies of Cancer Therapy Based on Ferroptosis[J]. Adv Mater, 2018, 30(12): e1704007. doi: 10.1002/adma.201704007
[35] Wang S, Li F, Qiao R, et al. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics[J]. ACS Nano, 2018, 12(12): 12380-12392. doi: 10.1021/acsnano.8b06399
-
下载:
图(1)
计量
- 文章访问数: 3172
- PDF下载数: 3401
- 施引文献: 0